Genelux Corp (GNLX)
2.005
-0.20
(-8.86%)
USD |
NASDAQ |
Jun 28, 16:00
2.11
+0.10
(+5.24%)
After-Hours: 20:00
Genelux Shareholders Equity (Quarterly): 15.08M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.08M |
| December 31, 2023 | 19.47M |
| September 30, 2023 | 24.03M |
| June 30, 2023 | 22.26M |
| March 31, 2023 | 2.691M |
| Date | Value |
|---|---|
| December 31, 2022 | -35.78M |
| September 30, 2022 | -32.33M |
| June 30, 2022 | -39.06M |
| March 31, 2022 | -36.54M |
| December 31, 2021 | -33.11M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-39.06M
Minimum
Jun 2022
24.03M
Maximum
Sep 2023
-9.330M
Average
-14.82M
Median
Shareholders Equity (Quarterly) Benchmarks
| Verastem Inc | 46.22M |
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 4.826M |
| IGC Pharma Inc | 7.321M |
| NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.68M |
| Total Liabilities (Quarterly) | 9.592M |
| Current Ratio | 2.717 |
| Net Debt Paydown Yield | 2.87% |